✦ LIBER ✦

Combinatorial Synthesis of anti-HIV Agents

✍ Scribed by Dharmarajan Sriram; Perumal Yogeeswari; Ananantha Naik Nagappa

Publisher: John Wiley and Sons
Year: 2006
Weight: 8 KB
Volume: 37
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200602233

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Total Synthesis of anti-HIV Agent Chloro

Total Synthesis of anti-HIV Agent Chloropeptin I (I).

✍ Hongbo Deng; Jae-Kyung Jung; Tao Liu; Kevin W. Kuntz; Marc L. Snapper; Amir H. H 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 68 KB 👁 1 views

ChemInform Abstract: Synthesis and Anti-

ChemInform Abstract: Synthesis and Anti-HIV Activity of Arylpiperazinyl Fluoroquinolones: A New Class of Anti-HIV Agents.

✍ Masahiko Hagihara; Hiroto Kashiwase; Tetsushi Katsube; Tomio Kimura; Tomoaki Kom 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 29 KB 👁 2 views

Synthesis of Enantiomerically Pure D-FDO

Synthesis of Enantiomerically Pure D-FDOC, an anti-HIV Agent.

✍ Shuli Mao; Martin Bouygues; Christopher Welch; Mirlinda Biba; Jen Chilenski; Ray 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 118 KB 👁 1 views

## Abstract For Abstract see ChemInform Abstract in Full Text.

New anti-HIV Agents and Targets

✍ Erik De Clercq 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 69 KB 👁 2 views

## Abstract For Abstract see ChemInform Abstract in Full Text.

Cyclotides as natural anti-HIV agents

✍ David C. Ireland; Conan K. L. Wang; Jennifer A. Wilson; Kirk R. Gustafson; David 📂 Article 📅 2007 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 327 KB 👁 2 views

## Abstract Cyclotides are disulfide rich macrocyclic plant peptides that are defined by their unique topology in which a head‐to‐tail cyclized backbone is knotted by the interlocking arrangement of three disulfide bonds. This cyclic cystine knot motif gives the cyclotides exceptional resistance to

New anti-HIV agents and targets

✍ Erik De Clercq 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB

## Abstract Virtually all the compounds that are currently used or are subject of advanced clinical trials for the treatment of HIV infections, belong to one of the following classes: (i) nucleoside reverse transcriptase inhibitors (NRTIs): i.e., zidovudine, didanosine, zalcitabine, stavudine, lami